– UK, Cardiff – Intelligent Ultrasound Group plc (LON: IUG), the ultrasound artificial intelligence (AI) software and simulation company, today announced the appointment of Michele Lesieur to its Board as a Non-executive Director with effect from 20 September 2021.
“I am delighted that Michele has chosen to join Intelligent Ultrasound as a Non-executive Director. She was an exceptional candidate for the position, with outstanding commercial experience in the medical imaging sector and her wealth of knowledge and understanding of the major imaging manufacturers can only benefit the Group, as we continue to expand our classroom to the clinic ultrasound business.” said Board chairman, Riccardo Pigliucci.
About Michele Lesieur
Michele Lesieur brings to the Company outstanding industry, corporate governance, and investor relations experience, having been CEO of Philips France and General Manager of Philips Healthcare France and most recently CEO of Euronext listed Supersonic Imagine, that was sold to Hologic in 2019 and Non-executive Director of EOS Imaging, a listed software MedTech company, sold to Nasdaq listed Alphatec Holdings, Inc in 2021.
Michele remains Chairman of the Board of Intrasense, a listed software MedTech company, and Non-executive Director of Prodways Group, a listed 3D printing company.
About Intelligent Ultrasound Group
Intelligent Ultrasound develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and high-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:
Clinical AI Division
Focuses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include:
ScanNav Assist uses machine-learning-based algorithms to automatically identify and grade ultrasound images. GE Healthcare’s SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received CE and FDA regulatory approval. SonoLyst is the world’s first fully integrated AI tool that recognizes the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.
ScanNav Anatomy PNB uses machine-learning-based algorithms to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting software for a range of medical procedures. ScanNav Anatomy has received CE approval and has also been submitted for FDA regulatory approval.
ScanNav Anatomy PNB is therefore not available for sale in the US or any other territory requiring government approval for this type of product.
Focusses on high-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module, and the new AI-based Anatomy PNB training simulator. To date over 1,000 simulators have been sold to over 600 medical institutions around the world.
For more information: https://www.intelligentultrasound.com/